Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Mar 6;22(5):1088–1099. doi: 10.1007/s10157-018-1549-3

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2019, corrected publication 2019

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

PMC Copyright notice

Fig. 1 — Distribution of parameters regarding coagulation and fibrinolytic factors of aHUS patients at the initial visit. Each level is expressed as median (range). a PT-INR (n = 60): 1.07 (0.76–1.44); eight patients with PT-INR > 1.25. b APTT (n = 59): 29.5 (15.3–67.1). c Fibrinogen (n = 53): 282 (76–572); five patients with fibrinogen < 150 mg/dl. d FDP (n = 53): 14.6 (0.5–194.0); 15 patients with FDP > 10 μg/dl. PT-INR international normalized ratio of prothrombin time, APTT activated partial thromboplastin time, FDP fibrinogen/fibrin degradation products